Can inadequate vitamin B12 availability contribute to neurologic dysfunction before MMA and homocysteine are checked?

Vitamin B12 is central to one-carbon metabolism and neural integrity. In an 83-year-old with compatible neurologic symptoms, inadequate B12 availability is a clinically credible contributor even when anemia, macrocytosis, MMA, or homocysteine results are absent or pending.

Clinical and neurologic relevance

• B12 deficiency can produce peripheral neuropathy, posterior-column dysfunction (loss of vibration/proprioception), gait imbalance or ataxia, myelopathy, and cognitive changes. These manifestations may occur without anemia or macrocytosis and are not excluded by a non-low total serum B12 concentration.
• Because neurologic injury, including demyelination affecting spinal white matter and peripheral nerves, can become incompletely reversible, clinically significant suspicion warrants clinician-directed assessment and management consideration before functional-marker results return.

Mechanistic basis

• B12 is the cofactor for methionine synthase, which remethylates homocysteine to methionine and regenerates tetrahydrofolate. Reduced enzyme activity limits methionine and S-adenosylmethionine (SAM), a principal methyl donor.
• This provides a biologically credible link between low B12 availability, impaired methylation capacity, and disrupted myelin protein/lipid homeostasis. Human tracer studies show reduced homocysteine remethylation in biochemical B12 deficiency, with improvement after B12 treatment.
• B12 also supports methylmalonyl-CoA mutase; deficiency can cause methylmalonic acid accumulation and altered lipid/metabolic handling that may further impair neural function.

Biomarker interpretation

• MMA and homocysteine are useful corroborative markers, not prerequisites for recognizing possible B12-related neurologic disease. MMA is relatively more specific; homocysteine is influenced by folate or B6 deficiency, hypothyroidism, and renal dysfunction. Renal impairment can elevate both, particularly MMA.

Bottom line

• The claim is well supported: B12-dependent methylation and myelin maintenance are biologically and clinically important, and possible B12-related neurologic dysfunction should be considered promptly while MMA and homocysteine testing is pending.